Phosphatidic acid-mediated activation of Rho proteins, which have been shown to be implicated in the progression in ovarian cancer (Horiuchi et al, 2003), could enhance invasion, metastasis and proliferation. The gene discussed is RHO; the disease is ovarian cancer.